Effects of Obeticholic Acid on Hepatic Fatty Acid/Triglyceride Metabolism and Hepatobiliary Detoxification/Elimination in Morbidly Obese and Gallstone Patients
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Gallstones; Obesity
- Focus Biomarker; Pharmacodynamics
- Acronyms OCABSGS
- 07 Jun 2017 Biomarkers information updated
- 15 Oct 2016 Status changed from recruiting to completed.
- 18 Feb 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.